Periogard Alcohol Free NDC 0126-0282

NDC codes

FDA NDC Directory

Product NDC (as listed)0126-0282Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00126-0282Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0126-0282-16	00126028216	473 mL in 1 BOTTLE, PLASTIC (0126-0282-16)Marketed from Oct 4, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Periogard Alcohol Free
Generic name (nonproprietary): chlorhexidine gluconate
Active ingredients: Chlorhexidine gluconate — 1.2 mg/mL
Dosage form: Rinse
Route: Buccal
Labeler: Colgate Oral Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203212
Marketing start: Oct 4, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Cell Wall Integrity (Physiologic effect)
Identifiers: Product ID 0126-0282_2eb30568-8cea-42ca-88f4-ca5add1c3d75SPL ID 2eb30568-8cea-42ca-88f4-ca5add1c3d75SPL set ID 4993fc4a-bbe2-5ccb-de4d-44d73d484d39RxCUI 834127, 834137UNII MOR84MUD8E

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Buccal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400126028216 followed by a unit qualifier and the quantity

Package 00126-0282-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 14, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE PerioGard® (Chlorhexidine Gluconate Oral Rinse USP, 0.12%) is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae, including gingival bleeding upon probing. PerioGard® has not been tested among patients with acute necrotizing ulcerative gingivitis (ANUG). For patients having coexisting gingivitis and periodontitis, see PRECAUTIONS .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203212

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203212
Product	Strength	Form · route	Labeler	Product NDC
Chlorhexidine Gluconate	Chlorhexidine gluconate 1.2 mg/mL	RinseBuccal	VistaPharm, LLC	66689-106
Periogard Alcohol Freechlorhexidine gluconate	Chlorhexidine gluconate 1.2 mg/mL	RinseBuccal	Colgate Oral Pharmaceuticals, Inc.	0126-0272
Periogard Alcohol Freechlorhexidine gluconate	Chlorhexidine gluconate 1.2 mg/mL	RinseBuccal	ATLANTIC BIOLOGICALS CORP.	17856-0272

Periogard Alcohol Free (chlorhexidine gluconate) NDC 0126-0282